PhaseBio Pharmaceuticals, Inc. filed its first amended combined plan of liquidation with related disclosure statement in the US Bankruptcy Court on April 19, 2024. As per the amended plan filed, Priority Non-Tax Claims, and Secured Claims are of $0. General Unsecured Claims are of $40.61 million and shall be recovered 1.7% i.e., $0.69 million of its pro rata share of distributable assets. There are no changes in treatment of any other claim class or sources of plan funding.